Prurigo Nodularis Clinical Trials in Berlin
3 recruitingBerlin, Germany
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
Prurigo Nodularis
Incyte Corporation330 enrolled120 locationsNCT06516952
Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Prurigo Nodularis
Galderma R&D600 enrolled51 locationsNCT06988618
Recruiting
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
Prurigo Nodularis
Sanofi150 enrolled11 locationsNCT06087627